Swiss Telecom Services and Carriers Stock News

What the latest earnings mean for Aevis Victoria Aevis Victoria (SWX:AEVS) has drawn investor attention after releasing full year 2025 results, with higher sales and revenue reported alongside a materially larger net loss and wider loss per share. The company reported sales of CHF 1,132.9 million and revenue of CHF 1,055.06 million for the year ended December 31, 2025. At the same time, Aevis Victoria posted a net loss of CHF 20.11 million, with basic and diluted loss per share from...

Swiss Prime Site (SWX:SPSN) has moved after the company appointed Martina Moosmann as Chief Financial Officer, formalising succession after an interim period and providing investors with fresh information about its senior financial leadership. See our latest analysis for Swiss Prime Site. The appointment appears to have sparked fresh interest, with the share price at CHF138.4 after a 1 day share price return of 1.10% and 7 day share price return of 4.93%. A 90 day share price return of 13.07%...

Why Swisscom’s tower plans are back in focus Swisscom (SWX:SCMN) recently held a shareholder and analyst call to lay out its perspective on a tower development initiative, putting the economics of its telecom infrastructure and potential use of towers on investors’ radar. See our latest analysis for Swisscom. At a share price of CHF671.5, Swisscom’s recent tower update comes after a 15.98% year to date share price return and a 34.67% total shareholder return over 1 year, suggesting that...

Avolta (SWX:AVOL) has drawn investor attention after securing a new 15 year food and beverage contract at Jacksonville International Airport in the US, alongside continued expansion of its integrated travel retail model across Latin America. See our latest analysis for Avolta. Recent contract wins at Jacksonville and the continued rollout of the integrated airport model in Latin America have come alongside a CHF49.64 share price, a 6.1% year-to-date share price return and a 47.7% total...

Readers hoping to buy Forbo Holding AG ( VTX:FORN ) for its dividend will need to make their move shortly, as the stock...

Readers hoping to buy Meier Tobler Group AG ( VTX:MTG ) for its dividend will need to make their move shortly, as the...

Intro Aevis Victoria (SWX:AEVS) has put fresh numbers on the table for FY 2025, with first half revenue of CHF 535.9 million and basic EPS of CHF 0.049, following CHF 420.0 million of revenue and a basic EPS loss of CHF 0.025 in the second half of FY 2024. Over the last three reported half year periods, revenue has moved from CHF 463.1 million in the first half of FY 2024 to CHF 420.0 million in the second half of FY 2024 and then to CHF 535.9 million in the first half of FY 2025. Over the...

Montana Aerospace (SWX:AERO) FY 2025 Earnings Snapshot Montana Aerospace (SWX:AERO) just posted its FY 2025 numbers with third quarter revenue at €256.2 million and basic EPS of €0.10, alongside net income from continuing operations of €6.1 million. The trailing twelve month view shows revenue of €1.6 billion and basic EPS of €0.49, which helps frame the bigger picture. Over recent periods, the company has reported revenue moving from €389.8 million in Q4 2023 to €440.3 million in Q4 2024 and...

ABB (SWX:ABBN) has drawn attention after its recent share performance, with a roughly 2% decline over the past month contrasted with a gain of about 11% over the past 3 months. See our latest analysis for ABB. At a share price of CHF65.84, ABB’s recent 2% one month share price decline contrasts with its 11% three month share price return and a 1 year total shareholder return of about 56%. This suggests momentum has been broadly positive even if short term sentiment has cooled. If you want to...

Roche Holding (SWX:ROP) has received CE marking for its cobas MPX-E assay, enabling simultaneous screening for HIV, hepatitis C, B, and E in blood donations. The company has also launched the cobas eplex RP3 respiratory panel, designed to test for up to 25 respiratory pathogens in a single rapid assay. These diagnostics products target blood safety, laboratory efficiency, and faster respiratory infection diagnosis across clinical settings. Roche Holding, trading at around CHF318.0,...

Amrize (SWX:AMRZ) has completed the acquisition of PB Materials Holdings, adding 26 locations across West Texas. The move increases Amrize’s presence in a region with significant infrastructure and energy related project activity. The transaction reflects Amrize’s push to grow business lines that are less tied to the residential construction cycle. Amrize, listed as SWX:AMRZ, now trades at CHF43.64 per share, with the stock showing a 0.8% decline over the past week and a 1.9% decline year...

Partners Group Holding (SWX:PGHN) has appointed Pete Zippelius as Co-Head of its Private Equity Health & Life vertical, sharpening its focus on healthcare and life sciences. The firm is also reported to be in early discussions to acquire a significant stake in Happiest Minds Technologies alongside other private equity investors. Partners Group Holding, trading at around CHF866.0, has seen mixed share performance, with a 4.2% gain over the past week and 5.6% over the past month, set against...

Warteck Invest AG's ( VTX:WARN ) robust earnings report didn't manage to move the market for its stock. We did some...

Jungfraubahn Holding (SWX:JFN) has reported its FY 2025 half year results with revenue of CHF 149.9 million and net income of CHF 37.1 million, translating to basic EPS of CHF 6.50. The trailing twelve month figures are CHF 302.7 million of revenue and CHF 78.5 million of net income with EPS of CHF 13.80. The company has reported revenue of CHF 141.8 million and EPS of CHF 6.07 in 2024 H1, and CHF 152.8 million and EPS of CHF 7.30 in 2024 H2. This sets up FY 2025 H1 against a backdrop where...

Lonza Group's FY 2025 Earnings Set The Stage For The Next Phase Of Its Story Lonza Group (SWX:LONN) has just posted its FY 2025 first half numbers, with revenue of CHF 3.6b and basic EPS of CHF 6.08, alongside trailing twelve month EPS of CHF 13.98 on revenue of about CHF 6.5b, putting fresh detail around the company’s recent earnings expansion narrative. The company has seen revenue move from CHF 3.1b in 1H 2024 to CHF 3.5b in 2H 2024 and CHF 3.6b in 1H 2025. Half year EPS shifted from CHF...

Banque Cantonale Vaudoise (SWX:BCVN) has reported full year 2025 results with second half revenue of CHF 570.6 million and net income of CHF 215.2 million, alongside a trailing twelve month net profit margin of 37.4%. The bank has seen trailing twelve month revenue track around CHF 1.15 billion and net income of CHF 429.7 million, with revenue across the last three reported half year periods ranging between CHF 570.6 million and CHF 579.3 million. With earnings growing at 5.4% per year over...

In March 2026, Sonova Holding AG announced plans to sell its Consumer Hearing business, which markets premium audio products under the Sennheiser brand, and said it will classify this unit as discontinued operations in its 2026 financial results. The move highlights a sharpened focus on Sonova’s core innovation areas in hearing care, while it simultaneously explores geo-targeted retail acquisitions to reshape its portfolio. Next, we’ll examine how exiting the Sennheiser-branded Consumer...

Implenia (SWX:IMPN) recently reported new building contracts in Switzerland and Germany worth more than CHF 310 million. These cover residential, commercial and institutional projects scheduled between 2026 and 2028, with a strong emphasis on timber and climate-friendly construction. See our latest analysis for Implenia. Despite the new CHF 310 million contract wins, Implenia’s share price has a 30 day share price return of 10.1% and a year to date share price return of 18%. At the same time,...

Recent performance snapshot Partners Group Holding (SWX:PGHN) has drawn attention after a recent share price move, with the stock up 2.6% over the past day and 4.6% over the past week on the Swiss market. See our latest analysis for Partners Group Holding. That short term momentum contrasts with a 90 day share price return of an 11.62% decline and a 1 year total shareholder return showing a 27.63% loss, while the 3 year total shareholder return of 16.27% points to a stronger longer run...

UBS Group (SWX:UBSG) is back in focus after reports that senior Swiss lawmakers plan to soften proposed capital rules, easing earlier concerns that a sharp regulatory shift might pressure the bank’s operating footprint. See our latest analysis for UBS Group. At a share price of CHF31.56, UBS Group’s recent 2.7% 1 day and 4.6% 7 day share price returns sit against a weaker 90 day share price return of 14.6% and a much stronger 5 year total shareholder return of 141.4%. This suggests that near...

In March 2026, Julius Bär Gruppe AG announced it would exercise its option to redeem all outstanding Perpetual Tier 1 Subordinated Bonds (ISIN: XS2238020445), originally issued on 8 October 2020 with a 4.875% coupon and an aggregate nominal amount of US$350,000,000, at par plus accrued interest on the first call date of 8 April 2026. This early redemption under condition 3(c) highlights Julius Bär’s active approach to capital structure management, reflecting how it balances funding costs,...

Why DKSH Holding (SWX:DKSH) is back on income investors’ radar DKSH Holding (SWX:DKSH) caught fresh attention after its March 27 annual general meeting, where shareholders backed a 6.4% dividend increase to CHF 2.50 per share and elected two new board members. See our latest analysis for DKSH Holding. Despite the dividend increase and board refresh, DKSH Holding's CHF58.0 share price sits below where it was a year ago, with a 1-year total shareholder return decline of 10.83%, while a modest...

Novartis (SWX:NOVN) is back in focus after recent share price moves, with the stock showing mixed returns over the past month and past 3 months. This puts current valuation and fundamentals under the spotlight for investors. See our latest analysis for Novartis. The recent share price pullback, with a 1 month share price return of a 5.5% decline after a stronger 3 month share price return of 12%, comes against a backdrop of stronger long term total shareholder returns of 30.7% over 1 year and...

Lonza recently published its 2025 Annual and Sustainability Reports, called its 2026 Annual General Meeting for 8 May in Basel, and proposed a 25% dividend increase alongside a broad board refresh. The nomination of former Eli Lilly executive Stephen Fry and other new directors with healthcare, automation, AI and biopharma expertise underscores Lonza’s emphasis on governance quality and future-focused capabilities in its core CDMO business. We’ll now explore how Lonza’s planned 25% dividend...